Related Experiment Video
Updated: Jun 23, 2026

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
The angiotensin converting enzyme gene I/D polymorphism in Polish rowers
P Cieszczyk1, K Krupecki, A Maciejewska
1Institute of Physical Culture, University of Szczecin, Szczecin, Poland.
Abstract:
Angiotensin converting enzyme gene (ACE) is the most frequent investigated gene in the context of genetic conditioning of sports-predispositions. Product of this gene is a key-element in the renin-angiotensin system responsible for the regulation of blood pressure. In this study DNA polymorphism in the ACE gene was studied in Polish rowers in order to examine the hypothesis that ACE genotype is associated with athletes performance. Fifty-five male Polish rowers including Olympic and World champions were recruited for this study. Control samples were prepared from 115 unrelated volunteers. PCR amplification of the insertion (I) or deletion (D) fragment of ACE gene was performed. Genotype distribution and allele frequencies were determined by genotype and gene counting. Significance was assessed by chi2 analysis. ACE genotype distributions amongst subjects and controls were in Hardy-Weinberg equilibrium. Compared with controls, the frequency of I allele differ significantly from that found in rower's group: 56.3% vs. 44.3%, (P=0.038) and ACE genotype frequency amongst the whole athletes group (30.9% II, 50.9% ID, 18.2% DD) was also different from expected values (control group 19.1% II, 50.4% ID, 30.4% DD; P=0.039). This data confirm a positive association of the I allele of ACE gene with endurance performance.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
